Empowering Rare Disease Therapeutic Innovation Through An Integrated Platform
G-Plume is a rare disease-focused platform that integrates patient registries, diagnostics, genomics, clinical execution and real-world evidence. We optimize decision-making and increase success rates throughout the entire therapeutic development lifecycle.
Global Rare‑Disease Challenge
Rare diseases affect more than 300 million people worldwide across over 7,000 conditions. Despite advances in genomics, cell and gene therapy, and precision medicine, more than 95% of rare diseases still lack approved treatments. Development is constrained by small and fragmented patient populations, delayed diagnosis, limited natural‑history data, unclear clinical endpoints, and slow trial enrollment.
Why G‑Plume Exists
G-Plume is a rare-disease–focused development platform integrating patient registries, clinical execution, genomics, and real-world evidence to improve decision-making and increase the probability of success across development programs.
Advance Rare Disease R&D—With Structure and Confidence
Aligning data, clinical execution, and regulatory considerations from early stages.
Standardized data enables earlier insight and better resource allocation.
Connecting innovators, clinical networks, and strategic capital.
⭐⭐⭐⭐⭐
In rare disease development, identifying patients and aligning regulatory expectations are constant challenges. G-Plume’s integrated approach allowed us to move faster with clearer insight and greater confidence. They are not just a CRO—they operate as a development partner.”
Chief Clinical Officer, Boston-based Gene Therapy Company
“G-Plume’s data-driven insights accelerated our rare-disease research and streamlined decision-making across teams. Their platform approach made a measurable impact on our development strategy.”
Director of Research, Biotech Company
Your rare-disease R&D questions answered
Find clear, expert answers to common questions about rare-disease research, data analytics, and clinical development. Explore how our consulting supports your next breakthrough.
We support rare-disease development through integrated data platforms, clinical execution, genomics, and real-world evidence generation.
We support rare-disease development through integrated data platforms, clinical execution, genomics, and real-world evidence generation.
We partner with biotech innovators, pharmaceutical companies, and research organizations focused on rare and complex diseases.
Our platform integrates data, execution, and evidence into a single system—enabling learning across programs, not just within one trial.
Latest insights & stories
Advancing Rare Disease Breakthroughs Through Insight and Collaboration
Stay informed with research insights, case studies, and perspectives from the evolving rare-disease ecosystem.
Genomics streamlines clinical trials
See how data-driven methods improved patient selection and trial outcomes in rare-disease research.
Global partnerships in research
Explore how international teams are advancing rare-disease therapies through collaboration.
Contact